Zephyrus Biosciences
Berkeley
About Zephyrus Biosciences
Zephyrus Biosciences provides research tools to enable protein analysis at the single-cell level. Addressing the burgeoning single-cell analysis market, our first product, the scWestern system, enables western blotting on individual cells for the first time. Researchers will utilize Zephyrus’s products to gain new insights into the biology of cancer, stem cells, neurology, and human disease and development. It was founded in 2013 and headquartered in Berkeley, California.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.9M
- Funding stage: M&A
- Last round: Series Unknown (Jun 2017)
- Website: zephyrusbio.com
- Phone: (184) 493-7497
Industries & Categories
Biotechnology, Hardware, Health Care
Social Profiles
Canonical: https://fsome.com/organization/zephyrus-biosciences-3020860 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.